American Journal of Epidemiology Vol. 155, No. 11 : 997-1006
Copyright © 2002 by The Johns Hopkins University School of Hygiene and Public Health
ORIGINAL CONTRIBUTIONS |
Hormone Replacement Therapy, Reproductive Factors, and the Incidence of Cataract and Cataract Surgery:
The Blue Mountains Eye Study
1 Department of Ophthalmology, University of Sydney, Westmead, New South Wales, Australia.
2 Westmead Millennium Institute, University of Sydney, Westmead, New South Wales, Australia.
3 Save Sight Institute, University of Sydney, Westmead, New South Wales, Australia.
4 Department of Public Health and Community Medicine, University of Sydney, Westmead, New South Wales, Australia.
The authors aimed to assess the relation between endogenous and exogenous female hormones and the incidence of age-related cataract and cataract surgery. The Blue Mountains Eye Study examined 2,072 women aged 49 years or older during 1992–1994, of whom 1,343 (74.0% of survivors) were reexamined after 5 years, during 1997–1999. Information on reproductive factors and use of hormone replacement therapy was collected using an interviewer-administered questionnaire. Lens photographs were graded for the presence of cortical, nuclear, and posterior subcapsular cataract at baseline and follow-up. Women who had ever used hormone replacement therapy had a decreased incidence of cortical cataract affecting any eye compared with never users (odds ratio = 0.7, 95% confidence interval: 0.4, 1.0). However, this was not statistically significant (odds ratio = 0.7, 95% confidence interval: 0.4, 1.1) when using the first affected eye. Older age at menarche was associated with an increased incidence of cataract surgery (odds ratio = 2.6, 95% confidence interval: 1.2, 5.7) and a significant trend for increasing incidence of nuclear cataract (p = 0.04). There was also a significant trend for decreasing incidence of cataract surgery with increasing duration of reproductive years (p = 0.009). These epidemiologic data provide some evidence that estrogen may play a protective role in reducing the incidence of age-related cataract and cataract surgery.
cataract; cataract extraction; hormone replacement therapy; incidence; women
Abbreviations: TGFß; transforming growth factor ß
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  V. Dumeaux, J. Johansen, A.-L. Borresen-Dale, and E. Lund Gene expression profiling of whole-blood samples from women exposed to hormone replacement therapy. Mol. Cancer Ther., April 1, 2006; 5(4): 868 - 876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Nirmalan, J. Katz, A. L. Robin, R. Ramakrishnan, R. Krishnadas, R. D. Thulasiraj, and J. M. Tielsch Female Reproductive Factors and Eye Disease in a Rural South Indian Population: The Aravind Comprehensive Eye Survey Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4273 - 4276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A J Lee, P Mitchell, E Rochtchina, and P R Healey Female reproductive factors and open angle glaucoma: the Blue Mountains Eye Study Br. J. Ophthalmol., November 1, 2003; 87(11): 1324 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, J. W. Simpkins, J. A. Dykens, and P. R. Cammarata Oxidative Damage to Human Lens Epithelial Cells in Culture: Estrogen Protection of Mitochondrial Potential, ATP, and Cell Viability Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 2067 - 2075. [Abstract] [Full Text] [PDF]
|
|